Zachary Roberts, EVP of R&D: Allogene Therapeutics ALLO Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $48,414.22
Shares · price: 27,199 sh · $1.78 a share
Held after: 488,054 sh
Stock: Allogene Therapeutics ALLO
Person: Zachary RobertsEVP of R&D
Trade date: 25/01/21
Filed: 25/01/23
Days to filing: 2 days

Sold 5.3% of holdings

Share of holding sold: 5.3%

Allogene Therapeutics trades, last 26 weeks

What else happened in Allogene Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/22~25/02/20

Zachary Roberts's recent trades

Zachary RobertsEVP of R&D
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$63.2K
35,700 sh
$63.2K
Filed 02/04
Traded 02/02
Zachary RobertsEVP of R&D
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$63.4K
35,700 sh
$63.4K
Filed 02/02
Traded 02/02
Zachary RobertsEVP of R&D
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$41K
26,269 sh
$41K
Filed 01/23
Traded 01/21
Zachary RobertsEVP of R&D
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$40.9K
26,269 sh
$40.9K
Filed 01/21
Traded 01/21
Zachary RobertsEVP of R&D
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$32K
18,832 sh
$32K
Filed 25/02/05
Traded 25/02/03